773P - Multicenter, Randomized, Double-Blind Phase Ii Study of Sorafenib Compared to Placebo with Best Supportive Care After Failure of Docetaxel in Metastatic Castration-Resistant Prostate Cancer
Autor: | Kramer, G., Maj-Hes, A., Hobisch, A., Shariat, S.F., Loidl, W. |
---|---|
Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv266-iv266 |
Databáze: | ScienceDirect |
Externí odkaz: |